The phase 3 PEGASUS trial found that patients with paroxysmal nocturnal hemoglobinuria (PNH) may still experience anemia following recommended therapies, underscoring the need for further research. In ...
LDH is a well-accepted biomarker of intravascular hemolysis that measures how effective a treatment is at inhibiting the destruction of red blood cells and has also demonstrated a correlation to ...
Verywell Health on MSN
Hemolytic anemia causes and treatment
Medically reviewed by Jordana Haber Hazan, MD Hemolytic anemia occurs when red blood cells are destroyed faster than they can ...
A novel drug combination, improvements in quality of life, and breakthrough hemolysis control are among the clinical highlights in paroxysmal nocturnal hemoglobinuria (PNH) presented at the 2024 ...
Hemolysis is the #1 source of preanalytical error and can impact potassium results—potentially leading to inappropriate or delayed patient treatment, unnecessary ...
BERLIN, Germany—Evidence of hemolysis was detected in the vast majority of patients undergoing pulsed-field ablation (PFA) for atrial fibrillation (AF) in a prospective study conducted at four ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback